Bhavna Rani

656 total citations
13 papers, 527 citations indexed

About

Bhavna Rani is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Bhavna Rani has authored 13 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Bhavna Rani's work include Liver physiology and pathology (5 papers), TGF-β signaling in diseases (4 papers) and Cancer Mechanisms and Therapy (3 papers). Bhavna Rani is often cited by papers focused on Liver physiology and pathology (5 papers), TGF-β signaling in diseases (4 papers) and Cancer Mechanisms and Therapy (3 papers). Bhavna Rani collaborates with scholars based in Italy, Sweden and Germany. Bhavna Rani's co-authors include Gianluigi Giannelli, Francesco Dituri, Yuan Cao, Giuseppe Palasciano, Nataša Pavlović, Femke Heindryckx, Pär Gerwins, Staffan Johansson, Siamak A. Kamranvar and Michael Ott and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

Bhavna Rani

13 papers receiving 523 citations

Peers

Bhavna Rani
Bhavna Rani
Citations per year, relative to Bhavna Rani Bhavna Rani (= 1×) peers Khushboo Irshad

Countries citing papers authored by Bhavna Rani

Since Specialization
Citations

This map shows the geographic impact of Bhavna Rani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhavna Rani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhavna Rani more than expected).

Fields of papers citing papers by Bhavna Rani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhavna Rani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhavna Rani. The network helps show where Bhavna Rani may publish in the future.

Co-authorship network of co-authors of Bhavna Rani

This figure shows the co-authorship network connecting the top 25 collaborators of Bhavna Rani. A scholar is included among the top collaborators of Bhavna Rani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhavna Rani. Bhavna Rani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rani, Bhavna, et al.. (2022). Contribution of integrin adhesion to cytokinetic abscission and genomic integrity. Frontiers in Cell and Developmental Biology. 10. 1048717–1048717. 1 indexed citations
2.
Kamranvar, Siamak A., Bhavna Rani, & Staffan Johansson. (2022). Cell Cycle Regulation by Integrin-Mediated Adhesion. Cells. 11(16). 2521–2521. 48 indexed citations
3.
Pavlović, Nataša, Bhavna Rani, Pär Gerwins, & Femke Heindryckx. (2019). Platelets as Key Factors in Hepatocellular Carcinoma. Cancers. 11(7). 1022–1022. 67 indexed citations
4.
Rani, Bhavna, Andrea Malfettone, Francesco Dituri, et al.. (2018). Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression. Cell Death and Disease. 9(3). 373–373. 39 indexed citations
5.
Malfettone, Andrea, Jitka Soukupová, Esther Bertrán, et al.. (2017). Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. Cancer Letters. 392. 39–50. 75 indexed citations
6.
Rani, Bhavna, Francesco Dituri, Andrea Malfettone, et al.. (2016). Galunisertib (LY2157299) Modulates Stemness in Hepatocellular Carcinoma. Journal of Hepatology. 64(2). S558–S558. 1 indexed citations
7.
Malfettone, Andrea, Jitka Soukupová, Joan Fernando, et al.. (2016). Crosstalk between TGF-B-Induced Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma. Journal of Hepatology. 64(2). S557–S557. 2 indexed citations
8.
Rani, Bhavna, Francesco Dituri, Yuan Cao, et al.. (2015). P0320 : Targeting TGF-beta I with the transforming growth factor receptor type I kinase inhibitor, LY2157299, modulates stemness-related biomarkers in hepatocellular carcinoma. Journal of Hepatology. 62. S429–S429. 2 indexed citations
9.
Rani, Bhavna. (2014). Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. World Journal of Gastroenterology. 20(15). 4128–4128. 31 indexed citations
10.
Yang, Dakai, Qinggong Yuan, Timo H. Lüdtke, et al.. (2014). MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells. Journal of Hepatology. 62(1). 101–110. 34 indexed citations
11.
Giannelli, Gianluigi, Bhavna Rani, Francesco Dituri, Yuan Cao, & Giuseppe Palasciano. (2014). Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment. Gut. 63(10). 1668–1676. 90 indexed citations
12.
Yuan, Qinggong, Komal Loya, Bhavna Rani, et al.. (2012). MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology. 57(1). 299–310. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026